include,reason,title,doi,pubmed_id
False," The article does not contain original data, as it presents a case report rather than a systematic review or randomized controlled trial.",hypoglycemia associated with high doses of sertraline and sulphonylurea compound in a noninsulin-dependent diabetes mellitus patient.,nan,10465860
True," The study meets the inclusion criteria as it is a systematic analysis of original data from 13 prospective cohort studies, comparing the American Diabetes Association and WHO diagnostic criteria for diabetes, and examines the association between glucose tolerance and mortality in adults.",glucose tolerance and mortality: comparison of who and american diabetes association diagnostic criteria. the decode study group. european diabetes epidemiology group. diabetes epidemiology: collaborative analysis of diagnostic criteria in europe.,nan,10466661
True," The study meets all the inclusion criteria as it is a systematic comparison of three first-line monotherapy strategies for type 2 diabetes, includes clinically relevant outcomes, and is a double-blind, randomized controlled trial in an outpatient setting.","a short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose.",nan,10558125
False," The article does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, but rather a general overview of oral pharmacologic management of type 2 diabetes.",oral pharmacologic management of type 2 diabetes.,nan,10605995
True," The article meets all the inclusion criteria as it is a systematic review of oral hypoglycemic agents in type 2 diabetes, includes clinically relevant outcomes, and is a high-quality study.",new directions in type 2 diabetes mellitus: an update of current oral antidiabetic therapy.,nan,10643211
True," The study meets all the inclusion criteria as it is a systematic review of studies on repaglinide in combination therapy for type 2 diabetes, includes adults of different races, ages, and genders, and focuses on clinically relevant outcomes.",[repaglinide in combination therapy in type 2 diabetes].,nan,10746009
False," The article is a non-systematic review of a medication of the month, which does not contain original data.",[pharma-clinics. medication of the month. glimepiride (amarylle)].,nan,10823010
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the effectiveness of two interventions (troglitazone and metformin) added to sulfonylurea therapy for patients with type 2 diabetes, and reports clinically relevant outcomes.",troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?,nan,10907625
False," The article does not contain original data, as it is a review of existing treatments for postprandial hyperglycemia.",[pharmacological treatment of postprandial hyperglycemia].,nan,10975046
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, uses sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes (mild hypoglycaemia).",does holiday hypoglycaemia exist?,nan,11019600
True," The study meets all the inclusion criteria as it is a fair quality study on adults with type 2 diabetes, uses a specific oral hypoglycemic drug (tolbutamide), and reports clinically relevant outcomes.","hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (withania somnifera, dunal) root.",nan,11116534
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses sulfonylureas as an intervention, and reports clinically relevant outcomes.",serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.,nan,11273476
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (gliclazide), and reports clinically relevant outcomes.",24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.,nan,11353879
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (including crossover trials) in an outpatient setting, and it reports original data on the effects of chromium supplementation on glucose tolerance, serum lipids, and drug dosage in individuals with type 2 diabetes.","the effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes.",nan,11376359
False, The article is a medication of the month overview and does not contain original data.,[pharma-clinics. medication of the month. repaglinide (novonorm)].,nan,11496727
True," The study meets all the inclusion criteria as it is a systematic review of repaglinide, a short-acting secretagogue, in the treatment of type 2 diabetes, and it includes clinically relevant outcomes.","[repaglinide, potentially a therapeutic improvement for diabetes mellitus type 2].",nan,11525087
True," The study meets all the inclusion criteria as it is a systematic review of endothelial dysfunction in type 2 diabetes, includes adults of different races, ages, and genders, and focuses on the effects of sulfonylureas and short-acting secretagogues on endothelial function.",endothelial dysfunction and type 2 diabetes. part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.,nan,11547217
False," The article does not contain original data, as it is a review of the thiazolidinediones class of oral antidiabetics.",[thiazolidinediones--a new class of oral antidiabetics].,nan,11715152
False," The abstract does not contain original data, as it appears to be a summary of regulatory submissions and does not report on a specific study or clinical trial.",pramlintide (amylin).,nan,11763160
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glimepiride as the intervention, and reports clinically relevant outcomes.",glimepiride in type 2 diabetes mellitus thai patients.,nan,11800292
False, The study does not meet the inclusion criteria as it does not focus on adults with type 2 diabetes and the intervention is not by sulfonylureas or short-acting secretagogues.,sibutramine: new preparation. slight weight loss; but also a slight rise in blood pressure ...,nan,11824428
False, The paper is a review article and does not contain original data.,"""a"" is for amylin and amyloid in type 2 diabetes mellitus.",nan,11875249
False," The study does not focus on adults with type 2 diabetes, but rather on polycystic ovary syndrome (PCOS), which is a different condition.","glucose tolerance, insulin secretion and insulin sensitivity in polycystic ovary syndrome.",nan,11884761
False," The article does not meet the inclusion criteria as it is a review of alternative therapies for type 2 diabetes, but it does not specify the type of intervention (sulfonylureas or short-acting secretagogues) or the type of study design (systematic review or double-blind, randomized controlled trial).",alternative therapies for type 2 diabetes.,nan,11896745
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as progression or occurrence of microvascular disease, quality of life, and all-cause mortality.","efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo‐controlled study in patients receiving stable insulin therapy",nan,12074206
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes, and examines the factors associated with switching from oral hypoglycaemic agents to insulin therapy in an outpatient setting.",factors associated with switching from oral hypoglycaemic agents to insulin therapy.,nan,12365467
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of discontinuing metformin in patients treated with insulin, with clinically relevant outcomes.",discontinuation of metformin in type 2 diabetes patients treated with insulin.,nan,12365468
False," The article does not contain original data, as it is a non-systematic review of existing treatments for type 2 diabetes mellitus.",therapeutic options for the management of type 2 diabetes mellitus.,nan,12437315
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it includes adults with type 2 diabetes, and it reports clinically relevant outcomes.",combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.,nan,12442064
False," The article does not contain original data, as it is a discussion piece without presenting any new research findings.",oral anti diabetic polychemotherapy in type 2 diabetes mellitus.,nan,12461471
True," The study meets all the inclusion criteria as it is a study on adults with type 2 diabetes, includes a fair quality analysis of the effects of sulfonylurea and metformin combination therapy, and reports clinically relevant outcomes.",[aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in dakar].,nan,12473527
True," The study meets all the inclusion criteria as it is a systematic review of the treatment of type 2 diabetes, includes adults of different races, ages, and genders, and focuses on clinically relevant outcomes.",treatment of type 2 diabetes: inadequate assessment of oral antidiabetic combinations.,nan,12602406
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes adults with type 2 diabetes, and examines the efficacy and safety of a short-acting secretagogue (nateglinide).",efficacy and safety of nateglinide in the treatment of type ii diabetes mellitus.,nan,12674176
False," The article is a critical review of insulin analogues, not a systematic review or double-blind, randomized controlled trial, and does not contain original data.",insulin analogues. a critical review.,nan,12685221
True," The study meets all the inclusion criteria as it is a systematic review of the effects of oral antidiabetic drugs on cardiovascular complications in type 2 diabetes patients, and it includes clinically relevant outcomes such as progression of microvascular disease and all-cause mortality.",[oral antidiabetic therapy and cardiovascular complications: theoretical problem or clinical evidence?].,nan,12795025
True," The study meets all the inclusion criteria as it is a systematic review of the effects of glimepiride, a second-generation sulfonylurea, in adults with type 2 diabetes, and it includes clinically relevant outcomes.",[glimepiride--an oral antidiabetic agent].,nan,12822388
True," The study meets all inclusion criteria as it is a systematic review of a specific antidiabetic agent, includes adults with type 2 diabetes, and focuses on clinically relevant outcomes.",nateglinide (starlix): update on a new antidiabetic agent.,nan,12918894
True," The study meets all the inclusion criteria as it is a systematic comparison of different treatments for type 2 diabetes after secondary oral antidiabetic drug failure, includes adults of different races, ages, and gender, and reports clinically relevant outcomes.",lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.,nan,12974145
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a randomized, open-label, crossover study in an outpatient setting, and it includes clinically relevant outcomes.",pharmacokinetics and pharmacodynamics of glipizide after once‐daily and divided doses,nan,7479199
True," The study meets all the inclusion criteria as it is a double-blind controlled trial involving adults with type 2 diabetes, comparing the efficacy of two oral hypoglycemic drugs, and reports clinically relevant outcomes.",comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.,nan,7556806
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glipizide) as an intervention, and reports clinically relevant outcomes.",effect of insulin-glipizide combination on skeletal muscle capillary basement membrane width in diabetic patients.,nan,7697692
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes treated with a sulfonylurea (chlorpropamide), and reports clinically relevant outcomes such as glucose control and insulin response.",[response of insulin and c-peptide to a mixed meal in non-insulin-dependent diabetics treated with insulin and chlorpropamide].,nan,7777712
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of glipizide, a sulfonylurea, in adults with type 2 diabetes, and reports clinically relevant outcomes.",one year comparative trial of metformin and glipizide in type 2 diabetes mellitus.,nan,7843470
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes such as mortality.",effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction.,nan,7858767
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes, and examines the effects of oral hypoglycemic agents (glibenclamide) on lipoprotein composition.",relation of abnormal composition of lipoproteins to hba1c levels in non-insulin dependent diabetes.,nan,7886271
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses glyburide as an intervention, is a double-blind, randomized controlled trial, and reports clinically relevant outcomes.",[a comparative study of insulin and glyburide versus glyburide or insulin in the chronic control of patients with type-2 diabetes].,nan,7926425
False," The study only investigates the effect of glipizide on metabolic clearance rate of insulin in a small sample of non-obese type 2 diabetic patients, which does not meet the inclusion criteria of including studies of different races, ages, and gender.",metabolic clearance rate of insulin in type 2 diabetic patients treated with combined insulin and sulfonylurea therapy.,nan,7991936
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses sulfonylureas as the intervention, and reports clinically relevant outcomes.",[effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].,nan,8015532
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses sulfonylurea derivatives as an intervention, and reports clinically relevant outcomes.",alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives.,nan,8053971
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of sulfonylureas (glyburide and glipizide) in adults with type 2 diabetes, and reports clinically relevant outcomes.","diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus.",nan,8111800
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a multicenter study, it involves adults with type 2 diabetes, and it examines the efficacy and safety of a sulfonylurea (gliclazide) in an outpatient setting.",efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a canadian multicenter study.,nan,8111803
False," The article does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, but rather a general overview of oral antidiabetic agents and insulin therapy.",[management of diabetes in general practice--current requirements. 2: oral antidiabetics and insulin therapy].,nan,8200602
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, involves adults with type 2 diabetes, and examines the efficacy and safety of a sulfonylurea (glyburide) as an intervention.","efficacy and safety of reformulated, micronized glyburide tablets in patients with non-insulin-dependent diabetes mellitus: a multicenter, double-blind, randomized trial.",nan,8269445
True," The study meets all the inclusion criteria as it is a good quality study on adults with type 2 diabetes, using a sulfonylurea (gliclazide) as the intervention, and reports clinically relevant outcomes.",effect of gliclazide on plasma lipids and pancreatic beta cell function in non-insulin-dependent diabetes mellitus.,nan,8313208
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it compares the effects of different treatments in an outpatient setting.","comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment.",nan,8529760
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial involving adults with type 2 diabetes, and it evaluates the efficacy of a specific sulfonylurea (glibenclamide) in combination with a traditional Chinese treatment.",randomized study of glibenclamide versus traditional chinese treatment in type 2 diabetic patients. chinese-french scientific committee for the study of diabetes.,nan,8593925
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not focus on the specified oral hypoglycemic drugs.",[activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes. effect of diabetic treatment on examined parameters].,nan,8596760
False," The article does not meet the inclusion criteria as it is a descriptive article about metformin, not a systematic review or double-blind, randomized controlled trial.",metformin: a new treatment option for non-insulin-dependent diabetes mellitus.,nan,8656173
True," The study meets all the inclusion criteria as it is a high-quality study on metformin in noninsulin-dependent diabetes mellitus, involving adults of different races, ages, and genders, and it discusses clinically relevant outcomes.",metformin in noninsulin-dependent diabetes mellitus.,nan,8726592
False, The study does not meet the inclusion criteria as it is focused on healthy subjects rather than adults with type 2 diabetes.,ø[the effect of physical exercise on glycemia on healthy subjects following administration of glimepiride].,nan,8767351
False," The article is a review of acarbose, not a systematic review or double-blind, randomized controlled trial.",a review of the safety and efficacy of acarbose in diabetes mellitus,nan,8888075
True," The study meets all the inclusion criteria as it is a systematic comparison of two insulin types in type 2 diabetes patients with secondary tolerance to sulfonylurea, conducted in an outpatient setting, and reports clinically relevant outcomes.",[comparative study of the efficiency of ultralente insulin and nph insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. possible selection criteria].,nan,9026680
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effects of a specific intervention (continuous subcutaneous insulin infusion) on clinically relevant outcomes.",short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment.,nan,9059766
True," The study meets all the inclusion criteria as it is a good quality study involving adults with type 2 diabetes, using a sulfonylurea (glibenclamide), and reports clinically relevant outcomes.",drug interaction: rifampicin and glibenclamide.,nan,9069698
True," The study meets all the inclusion criteria as it is a systematic review of the medical literature, includes adults with type 2 diabetes, and examines the effects of metformin in comparison to sulfonylureas.",treatment of non-insulin-dependent diabetes mellitus with metformin.,nan,9159660
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, involves adults with type 2 diabetes, and examines the effect of a sulfonylurea (glyburide) with another medication (bromfenac).",the influence of bromfenac on the pharmacokinetics and pharmacodynamic responses to glyburide in diabetic subjects,nan,9250558
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a prospective, open-label study in an outpatient setting, it involves adults with type 2 diabetes, and it examines the pharmacokinetics of glyburide, a sulfonylurea.",population pharmacokinetics of glyburide in patients with well‐controlled diabetes,nan,9469681
False," The study does not meet the inclusion criteria because it involves the use of multiple oral hypoglycemic agents (glibenclamide, gliclazide, and metformin) rather than a single class of drugs (sulfonylureas or short-acting secretagogues).",oxidative stress and metabolic control in non-insulin dependent diabetes mellitus.,nan,9594432
True," The study meets all the inclusion criteria as it is a double-blind, crossover, placebo-controlled trial in adults with type 2 diabetes, evaluating the efficacy of acarbose in improving glycemic control, and reports clinically relevant outcomes.","effect of acarbose in treatment of type ii diabetes mellitus: a double-blind, crossover, placebo-controlled trial.",nan,9623011
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of a sulfonylurea (glibenclamide) in combination with another oral hypoglycemic drug (kelening) in adults with type 2 diabetes, and reports clinically relevant outcomes.",[clinical study of glibenclamide in combination with kelening treatment in non-insulin dependent diabetes mellitus].,nan,9812648
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigating the effect of insulin treatment on retinopathy in elderly type 2 diabetic patients, and reports clinically relevant outcomes.",insulin treatment of elderly type 2 diabetic patients: effects on retinopathy.,nan,9881243
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, and examines the effect of a short-acting insulin (lispro) in comparison to regular insulin.",effects of regular insulin or insulin lispro on glucose metabolism after an oral glucose load in patients with type 2 diabetes mellitus.,nan,9932219
False, The study does not meet the inclusion criteria as it is focused on developing a cost-effectiveness model rather than presenting original data on the effectiveness of specific oral antidiabetic medicines.,a short term cost-effectiveness model for oral antidiabetic medicines in europe.,10.2165/00019053-199813030-00006,10178657
False," The study does not meet the inclusion criteria as it is a meta-regression analysis of published data, not a systematic review or double-blind, randomized controlled trial.","the relationship between glucose and incident cardiovascular events. a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.",https://doi.org/10.2337/diacare.22.2.233,10333939
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, compares the effects of two oral antidiabetic agents (sulphonylurea and biguanide derivative), and reports original data.",effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2),https://doi.org/10.1055/s-0031-1300423,10337452
True," The study meets all the inclusion criteria as it is a study on adults with type 2 diabetes treated by oral hypoglycemic agents, has original data, and is published in English.",morning blood glucose determination in the monitoring of metabolic control in type 2 elderly diabetic cases treated by oral hypoglycemic agents.,https://doi.org/10.3143/geriatrics.36.122,10363530
True," The study meets all the inclusion criteria as it is a systematic review of rosiglitazone's effects on type 2 diabetes, includes adults of different races, ages, and genders, and focuses on clinically relevant outcomes.",rosiglitazone,https://doi.org/10.2165/00003495-199957060-00007,10400405
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines the effects of a specific oral hypoglycemic drug (troglitazone) on clinically relevant outcomes.",vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus,https://doi.org/10.1161/01.hyp.34.1.83,10406828
True," The study meets all inclusion criteria as it is a high-quality study discussing a potential treatment for type 2 diabetes, includes adults of different races, ages, and genders, and discusses clinically relevant outcomes.","high-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type ii diabetes",https://doi.org/10.1054/mehy.1997.0682,10416947
False, The article does not meet the inclusion criteria as it does not involve the specified oral hypoglycemic drugs (sulfonylureas or short-acting secretagogues) and does not focus on adults with type 2 diabetes.,clinical pharmacokinetics and pharmacodynamics of bromfenac,https://doi.org/10.2165/00003088-199936060-00002,10427465
True," The article meets all the inclusion criteria as it is a systematic overview of type 2 diabetes, includes adults of different races, ages, and genders, and discusses clinically relevant outcomes.",type 2 diabetes: an overview,https://doi.org/10.1093/clinchem/45.8.1339,10430816
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses sulfonylureas as the intervention, and reports clinically relevant outcomes.",higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas,https://doi.org/10.1046/j.1464-5491.1999.00110.x,10445835
True," The study meets all the inclusion criteria as it is a systematic review of oral agents for type 2 diabetes, includes adults of different races, ages, and genders, and focuses on clinically relevant outcomes.",pharmacologic therapy for type 2 diabetes mellitus.,10.7326/0003-4819-131-4-199908170-00008,10454950
True, The study meets all the inclusion criteria as it is a good quality study examining the association between glucose intolerance and the risk of coronary heart disease and total mortality in a cohort of middle-aged and older Japanese-American men.,glucose intolerance and 23-year risk of coronary heart disease and total mortality: the honolulu heart program.,https://doi.org/10.2337/diacare.22.8.1262,10480768
True," The study meets all the inclusion criteria as it is a good quality study that investigates the effects of sulfonylureas on carnitine transport in human kidney proximal tubular epithelial cells, which is relevant to the management of type 2 diabetes.",carnitine transport and its inhibition by sulfonylureas in human kidney proximal tubular epithelial cells,https://doi.org/10.1016/s0006-2952(99)00219-1,10487540
False," The study does not meet the inclusion criteria as it is not a systematic review or a double-blind, randomized controlled trial, and it does not involve intervention with sulfonylureas or short-acting secretagogues.",the natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus,https://doi.org/10.1172/jci7231,10491414
False," The article does not meet the inclusion criteria as it is a pharmacokinetic study of a single oral antidiabetic agent, troglitazone, rather than a study comparing the effects of sulfonylureas or short-acting secretagogues.",clinical pharmacokinetics of troglitazone,https://doi.org/10.2165/00003088-199937020-00001,10496299
False," The study does not meet the inclusion criteria as it is focused on the in vitro metabolism of rosiglitazone, not the clinical effects of sulfonylureas or other oral hypoglycemic drugs in adults with type 2 diabetes.",characterization of the cytochrome p450 enzymes involved in the in vitro metabolism of rosiglitazone,https://doi.org/10.1046/j.1365-2125.1999.00030.x,10510156
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effects of sulphonylureas in combination with insulin on lipoprotein profiles in patients with type 2 diabetes.",the lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with type 2 diabetes mellitus,https://doi.org/10.1046/j.1464-5491.1999.00170.x,10547208
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",the role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal,https://doi.org/10.1046/j.1464-5491.1999.00171.x,10547209
False," The article does not contain original data, as it is a discussion of existing guidelines and recommendations rather than a systematic review or randomized controlled trial.",strategies for better diabetes control in the us,https://doi.org/10.2165/00003495-199958001-00014,10576528
True," The study meets all inclusion criteria as it is a systematic review of repaglinide, a short-acting secretagogue, in comparison to sulfonylureas, and it includes clinically relevant outcomes such as quality of life and all-cause mortality.",repaglinide â a new compound for the treatment of patients with type 2 diabetes,https://doi.org/10.1016/s0300-2977(99)00068-6,10593133
True," The study meets all the inclusion criteria as it is a systematic investigation of drug-drug interactions between thioctic acid and two oral hypoglycemic drugs, glibenclamide and acarbose, in healthy volunteers.","lack of interaction between thioctic acid, glibenclamide and acarbose",https://doi.org/10.1046/j.1365-2125.1999.00097.x,10594485
True," This study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of a short-acting secretagogue (repaglinide) in adults with type 2 diabetes, and reports clinically relevant outcomes.","repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study",https://doi.org/10.1177/00912700022008694,10631622
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a double-blind, randomized controlled trial, and it investigates the pharmacokinetics of repaglinide in adults with type 2 diabetes.",single‐dose pharmacokinetics of repaglinide in subjects with chronic liver disease,https://doi.org/10.1177/00912700022008793,10664920
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes,https://doi.org/10.1016/s0149-2918(00)87983-7,10688395
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes clinically relevant outcomes, and is of good quality.",addition of low‐dose rosiglitazone to sulphonylurea therapy improves glycaemic control in type 2 diabetic patients,https://doi.org/10.1046/j.1464-5491.2000.00224.x,10691158
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes of different races, and examines the pharmacokinetics and pharmacodynamics of a sulfonylurea, gliclazide.",pharmacokinetics and pharmacodynamics of gliclazide in caucasians and australian aborigines with type 2 diabetes,https://doi.org/10.1046/j.1365-2125.2000.00162.x,10718777
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it compares the efficacy of two sulfonylureas (glipizide and glyburide).",comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus,https://doi.org/10.1016/s0002-9629(15)40712-8,10746824
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial examining the effects of a short-acting secretagogue (nateglinide) on insulin secretion in patients with type 2 diabetes.",effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in type 2 diabetes mellitus,https://doi.org/10.1046/j.1464-5491.2000.00256.x,10784228
False," The study does not involve adults with type 2 diabetes, but rather healthy volunteers.",lack of interaction between tolcapone and tolbutamide in healthy volunteers,https://doi.org/10.1177/00912700022009161,10806608
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in adults with type 2 diabetes, investigating the efficacy and safety of cerivastatin, a specific oral hypoglycemic drug, in an outpatient setting.",efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolemia,https://doi.org/10.1177/204748739900600607,10817086
True," The study meets all the inclusion criteria, including being a good quality systematic review of a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (ukpds 41),https://doi.org/10.1136/bmj.320.7246.1373,10818026
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",erythromycin improves glycaemic control in patients with type ii diabetes mellitus,https://doi.org/10.1007/s001250051323,10819233
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, examining the effect of a short-acting secretagogue (repaglinide) on insulin secretion in adults with type 2 diabetes.",increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.,https://doi.org/10.2337/diacare.23.4.518,10857945
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it reports on clinically relevant outcomes such as glycemic control and quality of life in patients with type 2 diabetes.",rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.,https://doi.org/10.2337/diacare.23.2.202,10868832
True," This study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines the effect of a short-acting secretagogue (nateglinide) in combination with metformin.",improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.,https://doi.org/10.2337/diacare.23.3.349,10868864
True," This study meets all the inclusion criteria as it is a double-blind, crossover trial investigating the effects of nateglinide in patients with type-2 diabetes, and it reports original data.",mealtime glucose regulation by nateglinide in type-2 diabetes mellitus,https://doi.org/10.1007/s002280050730,10877006
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes.,https://doi.org/10.2337/diacare.23.7.979,10895850
True," The article meets all the inclusion criteria as it is a systematic review of therapeutic agents for type 2 diabetes mellitus, includes adults of different races, ages, and genders, and focuses on the use of sulfonylureas and short-acting secretagogues in an outpatient setting.",a rational approach to drug therapy of type 2 diabetes mellitus,https://doi.org/10.2165/00003495-200060010-00006,10929931
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it includes clinically relevant outcomes.",less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime nph insulin during insulin combination therapy in type 2 diabetes. hoe 901/3002 study group.,https://doi.org/10.2337/diacare.23.8.1130,10937510
True," The study meets all the inclusion criteria as it is a good quality study examining the association between the K121Q variant of the PC-1 gene and insulin resistance or type 2 diabetes in Danish Caucasians, and it reports original data.",the k121q variant of the human pc-1 gene is not associated with insulin resistance or type 2 diabetes among danish caucasians.,https://doi.org/10.2337/diabetes.49.9.1608,10969849
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, uses sulfonylureas as an intervention, and reports clinically relevant outcomes.",oral hypoglycaemic agents in 118 diabetic pregnancies,https://doi.org/10.1046/j.1464-5491.2000.00314.x,10972579
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it focuses on adults with type 2 diabetes, and it examines clinically relevant outcomes.","therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering hba1c. ioez study group.",https://doi.org/10.2337/diacare.23.9.1236,10977012
True," The study meets all the inclusion criteria as it is a systematic review of clinical trials on pioglitazone, includes adults with type 2 diabetes, and reports on clinically relevant outcomes.",pioglitazone,https://doi.org/10.2165/00003495-200060020-00009,10983737
True," The study meets all inclusion criteria as it is a systematic review of a double-blind, randomized controlled trial in adults with type 2 diabetes, comparing the effects of nateglinide with other treatments.",nateglinide,https://doi.org/10.2165/00003495-200060030-00007,11030470
True," The study meets all inclusion criteria, including being a systematic review of a double-blind, randomized controlled trial of a short-acting secretagogue in adults with type 2 diabetes, and reports clinically relevant outcomes.","pharmacological properties of nateglinide, rapid-onset/short-duration insulinotropic agent, in the treatment of type 2 diabetes.",https://doi.org/10.1254/fpj.116.171,11031747
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves the use of glyburide, a sulfonylurea, and it reports clinically relevant outcomes.",a comparison of glyburide and insulin in women with gestational diabetes mellitus,https://doi.org/10.1056/nejm200010193431601,11036118
True," The study meets all inclusion criteria as it is a systematic review of repaglinide, a specific oral antidiabetic agent, in adults with type 2 diabetes, and it reports on clinically relevant outcomes.",pharmacology and clinical experience with repaglinide,https://doi.org/10.1517/13543784.9.4.885,11060717
False, The article does not meet the inclusion criteria as it is a narrative review and does not contain original data.,management of type 2 diabetes mellitus and cardiovascular risk,https://doi.org/10.2165/00003495-200060050-00001,11129129
False," The article does not contain original data, as it is a non-systematic review.",recent advances in the pharmacologic management of diabetes mellitus,https://doi.org/10.1016/s0733-8627(05)70156-5,11130936
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, specifically a crossover trial, in an outpatient setting, and it investigates the effect of a sulfonylurea (glimepiride) on adults with diabetes.",effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride,https://doi.org/10.1046/j.1365-2125.2000.00295.x,11136298
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, assessing the efficacy of a short-acting secretagogue (repaglinide) in adults with type 2 diabetes, and reports clinically relevant outcomes.",flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes,https://doi.org/10.2337/diacare.24.1.11,11194214
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and reports original data on the prevalence of left ventricular diastolic dysfunction in this population.",diastolic dysfunction in normotensive men with well-controlled type 2 diabetes,https://doi.org/10.2337/diacare.24.1.5,11194240
False," The study does not involve adults with type 2 diabetes, but rather healthy volunteers.",mealtime glucose regulation with nateglinide in healthy volunteers,https://doi.org/10.2337/diacare.24.1.73,11194245
True," The study meets all the inclusion criteria, including being a systematic review of good quality studies on adults with type 2 diabetes, focusing on the effects of sulfonylureas and short-acting secretagogues.","beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus",https://doi.org/10.2165/00002512-200017060-00004,11200307
True," The study meets all the inclusion criteria as it is a systematic assessment of the effect of nateglinide, a short-acting secretagogue, on insulin secretion in obese patients with type 2 diabetes.","impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycemia seen in obese type 2 diabetes. assessment using nateglinide, a new insulin secretagogue.",https://doi.org/10.1507/endocrj.47.639,11200947
True," The study meets all the inclusion criteria as it is a systematic review of the effects and pharmacokinetics of oral sulfonylureas in patients with type 2 diabetes of different ethnicities, and it reports original data.",effects and pharmacokinetics of oral glibenclamide and glipizide in caucasian and chinese patients with type-2 diabetes,https://doi.org/10.1007/s002280000214,11214781
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes of different races, ages, and gender, and examines the effect of short-acting secretagogues (repaglinide and nateglinide) on leptin levels in female patients with type 2 diabetes mellitus.","leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus",https://doi.org/10.1046/j.1463-1326.2000.00073.x,11225747
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines the effect of a sulfonylurea (glybenclamide) and a short-acting secretagogue is not mentioned but metformin is an intervention that is relevant to the inclusion criteria.",the short-term effect of a switch from glybenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus,https://doi.org/10.1016/s0188-4409(00)00241-1,11257323
True," The study meets all the inclusion criteria as it is a fair quality study on adults with type 2 diabetes, investigating the effects of a specific intervention (oral combined hormone replacement therapy) on clinically relevant outcomes, and it contains original data.",lipid and lipoprotein responses to oral combined hormone replacement therapy in normolipemic obese women with controlled type 2 diabetes mellitus,https://doi.org/10.1177/009127009803801204,11301562
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigating the effects of a sulfonylurea (glibenclamide) on patients with cirrhosis and type 2 diabetes, and reports clinically relevant outcomes.","hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose",https://doi.org/10.1080/003655201750074654,11305519
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as an intervention, and reports clinically relevant outcomes.",sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia,https://doi.org/10.2337/diacare.24.4.738,11315840
True," The article meets all the inclusion criteria as it is a systematic review of glimepiride, a sulfonylurea for type 2 diabetes treatment, and includes clinically relevant outcomes.",clinical review of glimepiride,https://doi.org/10.1517/14656566.2.4.699,11336617
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in adults with type 2 diabetes, comparing the effects of nateglinide and glyburide, and reports clinically relevant outcomes.",importance of early insulin secretion,https://doi.org/10.2337/diacare.24.6.983,11375357
True," The article meets all the inclusion criteria as it is a systematic review of studies on type 2 diabetes treatment, includes adults of different races, ages, and genders, and focuses on clinically relevant outcomes.",matching treatment to pathophysiology in type 2 diabetes,https://doi.org/10.1016/s0149-2918(01)80017-5,11394726
False," The article does not contain original data, as it is a narrative review of the glitazones.",lessons from the glitazones: a story of drug development,https://doi.org/10.1016/s0140-6736(00)04960-6,11410214
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it reports original data on the efficacy of nateglinide in type 2 diabetic patients.",randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (a-4166),https://doi.org/10.2337/diacare.24.7.1221,11423506
True," The study meets all inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (gliclazide) as the intervention, and reports clinically relevant outcomes.",mechanisms of acute and chronic hypoglycemic action of gliclazide,https://doi.org/10.1007/s005920070006,11450504
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing the effectiveness of repaglinide and glipizide in adults with type 2 diabetes, and reports clinically relevant outcomes.",comparison between repaglinide and glipizide in type 2 diabetes mellitus: a 1‐year multicentre study,https://doi.org/10.1046/j.1464-5491.2001.00490.x,11472451
True," The study meets all the inclusion criteria as it is a systematic analysis of real-world drug utilization patterns in a U.S. population with type 2 diabetes, using a large administrative pharmacy claims database, and it focuses on oral hypoglycemic agents.",utilization of oral hypoglycemic agents in a drug-insured u.s. population,https://doi.org/10.2337/diacare.24.8.1411,11473078
True," This study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, evaluating the pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in patients with type 2 diabetes, and reports clinically relevant outcomes.","pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes",https://doi.org/10.1089/152091599317143,11475269
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effects of sulfonylureas and insulin on glucose control in a real-world setting.",differences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population‐based study,https://doi.org/10.1046/j.1463-1326.2001.00110.x,11520304
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",effects of improved glycaemic control on endothelial function in patients with type 2 diabetes,https://doi.org/10.1046/j.1445-5994.2001.00072.x,11529585
False, The article is a non-systematic review and does not contain original data.,objetivos y estrategia terapéutica en la diabetes mellitus tipo 2,https://doi.org/10.4321/s0212-71992001000700010,11534426
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and is a double-blind, randomized controlled trial in an outpatient setting.",intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in type 2 diabetes,https://doi.org/10.1046/j.1464-5491.2001.00522.x,11553186
True," The article meets all the inclusion criteria as it is a review of rosiglitazone in type 2 diabetes mellitus, includes good quality and fair quality studies, and focuses on adults with type 2 diabetes.",a review of rosiglitazone in type 2 diabetes mellitus,https://doi.org/10.1592/phco.21.13.1082.34615,11560198
False," The study does not meet the inclusion criteria as it focuses on cystic fibrosis-related diabetes, which is not specified in the inclusion criteria, and the intervention is insulin lispro or repaglinide, not sulfonylureas or short-acting secretagogues.",insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis–related diabetes,https://doi.org/10.2337/diacare.24.10.1706,11574430
False," The study does not meet the inclusion criteria for intervention, as it only reports on the prevalence of postchallenge hyperglycemia and does not investigate the effect of sulfonylureas or short-acting secretagogues.",postchallenge hyperglycemia in a national sample of u.s. adults with type 2 diabetes,https://doi.org/10.2337/diacare.24.10.1734,11574434
False," The article does not contain original data, as it is a descriptive introduction to a new drug, nateglinide, without presenting any systematic review or original research findings.",nateglinide: a new rapid-acting insulinotropic agent,https://doi.org/10.1517/14656566.2.6.1027,11585005
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes clinically relevant outcomes, and is a fair quality study.",improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients,https://doi.org/10.1046/j.1464-5491.2001.00582.x,11678974
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes clinically relevant outcomes, and is of good quality.",effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control,https://doi.org/10.2337/diacare.24.11.1957,11679464
False," The study does not meet the inclusion criteria as it is not a systematic review or a double-blind, randomized controlled trial, and it does not involve an intervention with sulfonylureas or short-acting secretagogues.",genetic variability of the sur1 promoter in relation to beta-cell function and type ii diabetes mellitus,https://doi.org/10.1007/s001250100651,11692183
False," The abstract does not mention any specific studies or data, but rather provides a general overview of diabetes diagnosis and prevention, and does not meet the inclusion criteria of containing original data or being a systematic review or randomized controlled trial.",medical care from childhood to adulthood in type 1 and type 2 diabetes,https://doi.org/10.1007/bf03343914,11716156
True," The study meets all the inclusion criteria as it is a systematic review of prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain, includes adults with type 2 diabetes, and reports on clinically relevant outcomes.",prescribing patterns and therapeutic implications for diabetic hypertension in bahrain,https://doi.org/10.1345/aph.10399,11724081
True," The study meets all inclusion criteria as it is a review of nateglinide therapy for type 2 diabetes mellitus, includes good and fair quality studies, and focuses on adults with type 2 diabetes, comparing nateglinide with other sulfonylureas and short-acting secretagogues.",nateglinide therapy for type 2 diabetes mellitus,https://doi.org/10.1345/aph.1a061,11724096
False," The article does not contain original data, as it appears to be a discussion of the potential benefits of meglitinide analogues without presenting any new research findings.",insulinotropic meglitinide analogues,https://doi.org/10.1016/s0140-6736(01)06715-0,11728565
True," The study meets all the inclusion criteria as it is a systematic review of good quality studies involving adults with type 2 diabetes, comparing the effects of orlistat with sulfonylureas and short-acting secretagogues, and reports clinically relevant outcomes.",orlistat,https://doi.org/10.2165/00003495-200161140-00011,11735640
True," The study meets all the inclusion criteria as it is a review of oral antihyperglycemic therapy for type 2 diabetes, includes good and fair quality studies, and focuses on clinically relevant outcomes.",oral antihyperglycemic therapy for type 2 diabetes,https://doi.org/10.1001/jama.287.3.360,11790216
True," The study meets all the inclusion criteria as it is a systematic review of a randomized controlled trial in adults with type 2 diabetes, evaluating the efficacy of adding insulin to sulfonylurea therapy, and reports clinically relevant outcomes.",sulfonylurea inadequacy,https://doi.org/10.2337/diacare.25.2.330,11815505
True," The study is a double-blind, randomized, parallel-group trial that meets the inclusion criteria of being a systematic review or double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of a short-acting secretagogue (repaglinide) on adults with type 2 diabetes.",optimizing insulin secretagogue therapy in patients with type 2 diabetes,https://doi.org/10.2337/diacare.25.2.342,11815507
True," The study meets all the inclusion criteria as it involves adults with type 2 diabetes of different races, ages, and gender, and it is a systematic approach using artificial neural networks to model the pharmacokinetics and pharmacodynamics of repaglinide.",modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks.,https://doi.org/10.1023/a:1013611617787,11837705
False, The article does not meet the inclusion criteria as it is a review of existing knowledge rather than a study with original data.,new trends in the development of oral antidiabetic drugs,https://doi.org/10.2174/0929867023371427,11860348
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in adults with type 2 diabetes, examining the effect of a sulfonylurea (glibenclamide) on vascular ATP-sensitive potassium channels.","vascular katp channel blockade by glibenclamide, but not by acarbose, in patients with type ii diabetes",https://doi.org/10.1042/cs1020307,11869171
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea drug (glibenclamide) as an intervention, and reports clinically relevant outcomes (myocardial dysfunction).",effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes,https://doi.org/10.2337/diabetes.51.3.808,11872684
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, examining the effects of glimepiride and metformin compared to glibenclamide in adults with type 2 diabetes.",vascular effects of glibenclamide vs. glimepiride and metformin in type 2 diabetic patients,https://doi.org/10.1046/j.1464-5491.2002.00663.x,11874430
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",the effects of intensive glycaemic control on body composition in patients with type 2 diabetes,https://doi.org/10.1046/j.1463-1326.2001.00153.x,11903412
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, assessing the effect of glimepiride on adults with impaired fasting glucose, and reports clinically relevant outcomes.",the nepi antidiabetes study (nansy). 1: short‐term dose–effect relations of glimepiride in subjects with impaired fasting glucose*,https://doi.org/10.1046/j.1463-1326.2001.00166.x,11903417
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a relevant intervention (diet with voglibose or glyburide), and reports clinically relevant outcomes.",effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes,https://doi.org/10.2337/diacare.25.4.658,11919121
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effects of sulfonylurea and metformin monotherapy compared to polytherapy.",patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients,https://doi.org/10.1177/147323000203000111,11921502
False," The study does not meet the inclusion criteria as it is not focused on type 2 diabetes, sulfonylureas, or short-acting secretagogues, and it is not a systematic review or double-blind, randomized controlled trial.",evaluation of innovative skin-marking technique performed before thyroid ultrasound-guided fine-needle aspiration biopsies,https://doi.org/10.4158/ep.8.1.5,11939753
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",a rapid increase in β‐cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment,https://doi.org/10.1046/j.1365-2796.2002.00956.x,11952881
False, The article is a non-systematic review and does not contain original data.,current oral agents for type 2 diabetes,https://doi.org/10.3810/pgm.2002.05.1194,12040862
False, The article is a review paper and does not contain original data.,multiple drug targets in the management of type 2 diabetes,https://doi.org/10.2174/1389450023347803,12041735
True," The study meets all the inclusion criteria as it is a systematic comparison of two glipizide formulations in patients with type 2 diabetes, and it reports original data.",pharmacokinetics and pharmacodynamics of extended‐release glipizide gits compared with immediate‐release glipizide in patients with type ii diabetes mellitus,https://doi.org/10.1177/00970002042006007,12043953
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, evaluating the effect of nateglinide, a short-acting secretagogue, on glycaemic control in adults with type 2 diabetes.",nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients,https://doi.org/10.1046/j.1463-1326.2002.00196.x,12047396
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes,https://doi.org/10.1046/j.1463-1326.2002.00211.x,12047399
False," The article does not contain original data, as it is a description of the pharmacokinetics and pharmacodynamics of repaglinide.",clinical pharmacokinetics and pharmacodynamics of repaglinide,https://doi.org/10.2165/00003088-200241070-00002,12083976
True," The study meets all the inclusion criteria as it is a systematic review of randomized, placebo-controlled studies in adults with type 2 diabetes, and it reports clinically relevant outcomes.",orlistat use in type 2 diabetes,https://doi.org/10.1345/aph.1a422,12086556
False, The article is a commentary and does not contain original data.,desensitization of insulin secretion,https://doi.org/10.1016/s0006-2952(02)00996-6,12093468
False," The article is a non-systematic review, as stated in the abstract, and does not contain original data.",oral hypoglycemic agents and the pregnant diabetic: “from bench to bedside”,https://doi.org/10.1053/sper.2002.33960,12099312
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses relevant interventions (sulfonylureas and short-acting secretagogues), and reports clinically relevant outcomes.",changes in treatment after the start of oral hypoglycaemic therapy in type 2 diabetes: a population-based study,https://doi.org/10.1046/j.1464-5491.2002.00743.x,12099966
False," The study does not meet the inclusion criteria as it is focused on bioequivalence evaluation of two brands of gliclazide tablets in healthy volunteers, not adults with type 2 diabetes, and does not involve the specified interventions.",bioequivalence evaluation of two brands of gliclazide 80 mg tablets (glyzide®& diamicron®) - in healthy human volunteers,https://doi.org/10.1002/bdd.310,12116051
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, evaluating the efficacy of a sulfonylurea (glibenclamide) in combination with metformin in adults with type 2 diabetes, and reports clinically relevant outcomes such as glycated haemoglobin (HbA1c) and fasting plasma glucose (FPG).",improved glycaemic control with metformin–glibenclamide combined tablet therapy (glucovance®) in type 2 diabetic patients inadequately controlled on metformin,https://doi.org/10.1046/j.1464-5491.2002.00774.x,12147149
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes adults with type 2 diabetes, and reports clinically relevant outcomes.",combination therapy with nateglinide and a thiazolidinedione improves glycemic control in type 2 diabetes,https://doi.org/10.2337/diacare.25.9.1529,12196422
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glimepiride) as the intervention, and reports clinically relevant outcomes.",glimepiride improves both first and second phases of insulin secretion in type 2 diabetes,https://doi.org/10.2337/diacare.25.9.1607,12196435
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effects of a sulfonylurea (gliclazide) on clinically relevant outcomes in type 2 diabetic patients.",gliclazide improves anti‐oxidant status and nitric oxide‐mediated vasodilation in type 2 diabetes,https://doi.org/10.1046/j.1464-5491.2002.00762.x,12207812
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses a short-acting secretagogue (repaglinide), and reports clinically relevant outcomes such as patient satisfaction and perceived glucose control.",patient perceptions of prandial oral therapy for type 2 diabetes,https://doi.org/10.1177/014572170102700507,12212016
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",tablet-breaking ability of older persons with type 2 diabetes mellitus,https://doi.org/10.1177/014572170102700408,12212341
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it compares the effects of repaglinide and metformin in combination with bedtime NPH insulin on glycemic control and weight gain.",repaglinide versus metformin in combination with bedtime nph insulin in patients with type 2 diabetes established on insulin/metformin combination therapy,https://doi.org/10.2337/diacare.25.10.1685,12351462
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting, and it includes clinically relevant outcomes such as progression or occurrence of microvascular disease and quality of life.",a diabetes outcome progression trial (adopt),https://doi.org/10.2337/diacare.25.10.1737,12351470
True," The study meets all the inclusion criteria as it is a systematic retrospective cohort analysis of adults with type 2 diabetes, comparing the effectiveness of a physician-pharmacist collaborative drug therapy management clinic with standard care, and reports clinically relevant outcomes such as glycemic control and quality of life.",a retrospective cohort analysis of the clinical effectiveness of a physician‐pharmacist collaborative drug therapy management diabetes clinic,https://doi.org/10.1592/phco.22.15.1294.33476,12389879
False," The abstract does not contain original data, as it is a review of existing literature and does not present new findings.",oral antihyperglycemic agents during pregnancy and lactation,https://doi.org/10.2165/00128072-200204110-00007,12390047
False," The article does not contain original data, as it is a review of the history of troglitazone from discovery through clinical development.",troglitazone: the discovery and development of a novel therapy for the treatment of type 2 diabetes mellitus,https://doi.org/10.1016/s0169-409x(02)00093-5,12393300
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it compares the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control.",a comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes,https://doi.org/10.2337/diacare.25.11.2058,12401757
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it includes adults with type 2 diabetes, and it assesses clinically relevant outcomes.",glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy,https://doi.org/10.1046/j.1463-1326.2002.00229.x,12406033
False, The article does not meet the inclusion criteria as it does not focus on the specified oral hypoglycemic drugs (sulfonylureas and short-acting secretagogues) and their effects on plasminogen activator inhibitor-1 in adults with type 2 diabetes.,"plasminogen activator inhibitor‐1: physiologic role, regulation, and the influence of common pharmacologic agents",https://doi.org/10.1177/009127002762491271,12412817
False," The abstract does not contain original data, as it is a discussion of the contentious nature of gestational diabetes and its treatment, rather than presenting new research findings.","the contentious nature of gestational diabetes: diet, insulin, glyburide and metformin",https://doi.org/10.1517/14656566.3.11.1557,12437490
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines the effect of a sulfonylurea (glipizide) and a short-acting secretagogue is not mentioned but metformin is a biguanide which is a different class but the study meets the inclusion criteria for sulfonylureas.",effect of combination glipizide gits/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects,https://doi.org/10.2337/diacare.25.12.2123,12453948
True," The study meets all inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of a short-acting secretagogue (nateglinide) on adults with impaired glucose tolerance.",nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population,https://doi.org/10.2337/diacare.25.12.2141,12453951
False," The study does not meet the inclusion criteria as it is focused on the development of a method for high-throughput inhibition screening of human cytochrome P450 enzymes, not on the treatment of type 2 diabetes with sulfonylureas or short-acting secretagogues.",high-throughput inhibition screening of major human cytochrome p450 enzymes using an in vitro cocktail and liquid chromatography–tandem mass spectrometry,https://doi.org/10.1016/s0731-7085(02)00480-6,12467917
True," The study meets all the inclusion criteria as it is a good quality study that includes adults with type 2 diabetes, uses sulfonylureas as an intervention, and reports clinically relevant outcomes.",does type 2 diabetes mellitus delay renal failure in autosomal dominant polycystic kidney disease?,https://doi.org/10.1081/jdi-120015682,12472202
False," The study does not meet the inclusion criteria as it does not involve adults with type 2 diabetes, but rather healthy subjects.",effects of inhibition of atp-sensitive potassium channels on metabolic vasodilation in the human forearm,https://doi.org/10.1042/cs1040039,12519086
False, The study does not meet the inclusion criteria as it does not involve sulfonylureas or short-acting secretagogues as interventions.,"tolbutamide, flurbiprofen, and losartan as probes of cyp2c9 activity in humans",https://doi.org/10.1177/0091270002239710,12520632
False," The article does not meet the inclusion criteria as it does not involve the specified interventions (sulfonylureas or short-acting secretagogues) or outcomes (microvascular disease, other complications of diabetes, quality of life, and all-cause mortality) in adults with type 2 diabetes.",the angiotensin-receptor blockers: from antihypertensives to cardiovascular all-round medications in 10 years?,https://doi.org/10.1080/080370502321095285,12523675
False," The article does not meet the inclusion criteria as it is a research paper focused on the molecular basis of KIR6.2 channel inhibition by adenine nucleotides, not a study on the effects of sulfonylureas or other oral hypoglycemic drugs in patients with type 2 diabetes.",molecular basis for kir6.2 channel inhibition by adenine nucleotides,https://doi.org/10.1016/s0006-3495(03)74847-4,12524280
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigating the effect of two specific oral hypoglycemic drugs (acarbose and glibenclamide) on insulin sensitivity in adults with type 2 diabetes.",influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients,https://doi.org/10.1046/j.1463-1326.2003.00239.x,12542723
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glimepiride) as the intervention, and reports clinically relevant outcomes.",plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects,https://doi.org/10.2337/diacare.26.2.285,12547850
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a double-blind, randomized controlled trial, it includes adults with type 2 diabetes, and it reports clinically relevant outcomes.",multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,https://doi.org/10.1056/nejmoa021778,12556541
True," The study meets all the inclusion criteria as it is a systematic review of oral therapy options for diabetes mellitus in older people, includes adults with type 2 diabetes of different races, ages, and gender, and focuses on clinically relevant outcomes.",treatment of diabetes mellitus in older people: oral therapy options,https://doi.org/10.1046/j.1532-5415.2003.51070.x,12558728
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it examines the effect of a sulfonylurea (glyburide) on clinically relevant outcomes in adults with type 2 diabetes.",rosiglitazone reduces urinary albumin excretion in type ii diabetes,https://doi.org/10.1038/sj.jhh.1001444,12571611
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glyburide) as the intervention, and reports clinically relevant outcomes.",beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus,https://doi.org/10.1097/00000441-200302000-00003,12589230
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a short-acting secretagogue (repaglinide), and reports clinically relevant outcomes.",safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function,https://doi.org/10.2337/diacare.26.3.886,12610054
True," This study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a relevant intervention (nateglinide), and reports clinically relevant outcomes.",pharmacokinetics of nateglinide in renally impaired diabetic patients,https://doi.org/10.1177/0091270002239825,12616669
False," The article does not contain original data, as it is a review of existing knowledge on the topic.",the relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes,https://doi.org/10.1007/s00125-002-1009-0,12637977
False," The abstract does not mention any original data or clinical trials, but rather a review of existing data and the potential role of an in vitro model.",maternal-fetal transport of hypoglycaemic drugs,https://doi.org/10.2165/00003088-200342040-00001,12648023
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it reports original data on the effect of oral magnesium supplementation on insulin sensitivity and metabolic control in type 2 diabetic patients.",oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects,https://doi.org/10.2337/diacare.26.4.1147,12663588
False," The abstract does not contain original data, as it appears to be a non-systematic review or an editorial discussing the relationship between obesity and type-2 diabetes in the elderly.",obesity and type-2 diabetes in the elderly,https://doi.org/10.1159/000069176,12679603
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of excluding glibenclamide in the treatment of ica+ type 2 diabetic patients.",slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment,https://doi.org/10.1080/0891693021000050574,12685875
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes of different races, ages, and gender, and focuses on the effects of nateglinide, a short-acting secretagogue.","evaluation of the effects of nateglinide on postprandial glycemia in patients with type 2 diabetes mellitus: a multicenter, multinational, non-randomized, non-controlled latin american study",https://doi.org/10.1159/000069534,12711836
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it includes clinically relevant outcomes.",addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis b or c,https://doi.org/10.1089/152091503763816445,12725705
False," The paper is a review of existing literature rather than a systematic review or double-blind, randomized controlled trial, and it does not contain original data.",chromium as adjunctive treatment for type 2 diabetes,https://doi.org/10.1345/aph.1c304,12773078
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, assessing clinically relevant outcomes such as quality of life and treatment satisfaction in adults with type 2 diabetes.","the effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve type 2 diabetes: a placebo-controlled, multicentre study.",https://doi.org/10.1023/a:1023495106160,12797714
True," The study meets all the inclusion criteria as it is a double-blind, crossover study of adults with type 2 diabetes, comparing the effects of two sulfonylureas (glimepiride and gliclazide) as add-on therapy to metformin, and reports clinically relevant outcomes.","comparison of the micro‐ and macro‐vascular effects of glimepiride and gliclazide in metformin‐treated patients with type 2 diabetes: a double‐blind, crossover study",https://doi.org/10.1046/j.1365-2125.2003.01781.x,12814458
False, The article is a non-systematic review and does not contain original data.,analysis: a flaw in the use of sulfonylurea screening to diagnose sulfonylurea overdosages,https://doi.org/10.1089/152091503765691965,12828830
True," The study meets all inclusion criteria as it is a review of the worldwide therapeutic experience of glimepiride in type 2 diabetes, includes good quality and fair quality studies, and focuses on clinically relevant outcomes.",glimerpiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience,https://doi.org/10.1016/s0149-2918(03)80109-1,12852703
True," The study meets all the inclusion criteria as it is a systematic review of the effectiveness and costs of first-line oral antihyperglycaemic medications in type 2 diabetes mellitus, includes adults of different races, ages, and gender, and focuses on clinically relevant outcomes.",economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus,https://doi.org/10.2165/00019053-200321110-00005,12859222
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes clinically relevant outcomes, and is of good quality.",effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes,https://doi.org/10.2337/diacare.26.8.2370,12882864
False," The article is a case report and literature review, which does not contain original data.",possible heart failure exacerbation associated with rosiglitazone: case report and literature review,https://doi.org/10.1592/phco.23.7.945.32721,12885108
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the pharmacokinetics of a short-acting secretagogue (nateglinide).",pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure,https://doi.org/10.5414/cnp60090,12940610
True," The study meets all inclusion criteria as it is a systematic review of the pharmacological regulation of mealtime glucose excursions in type 2 diabetics, specifically focusing on repaglinide and nateglinide, and includes clinically relevant outcomes.",cardiovascular risk in type 2 diabetics and pharmacological regulation of mealtime glucose excursions,https://doi.org/10.1016/s1262-3636(07)70044-7,14526261
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it reports original data on the effect of policosanol in patients with type 2 diabetes and hypercholesterolemia.",treatment of hypercholesterolemia in niddm with policosanol,https://doi.org/10.2337/diacare.18.3.393,7555484
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea as the intervention, and reports on clinically relevant outcomes.",energy expenditure in type 2 diabetic patients on metformin and sulphonylurea therapy,https://doi.org/10.1111/j.1464-5491.1995.tb00503.x,7648802
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glyburide), and reports on clinically relevant outcomes.",the influence of orlistat on the pharmacokinetics and pharmacodynamics of glyburide in healthy volunteers,https://doi.org/10.1002/j.1552-4604.1995.tb04098.x,7657854
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, comparing the effects of glipizide and insulin in patients with non-insulin-dependent diabetes mellitus, and reports clinically relevant outcomes.",insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus*effects on blood pressure and glucose tolerance,https://doi.org/10.1016/0895-7061(95)00052-q,7662219
True," The study meets all the inclusion criteria, including being a good quality study, focusing on adults with type 2 diabetes, using a sulfonylurea (glipizide) as an intervention, and reporting clinically relevant outcomes.",prolongation of near-normoglycemic remission in black niddm subjects with chronic low-dose sulfonylurea treatment,https://doi.org/10.2337/diab.44.4.466,7698517
True," The study meets all the inclusion criteria as it is a good quality study examining insulin sensitivity and glucose disposal in black and white Americans at risk for type 2 diabetes, and it reports original data.",minimal model analyses of insulin sensitivity and glucose‐dependent glucose disposal in black and white americans: a study of persons at risk for type 2 diabetes,https://doi.org/10.1111/j.1365-2362.1994.tb02029.x,7705380
False," The study does not meet the inclusion criteria as it does not involve adults with type 2 diabetes, but rather normal subjects.",acute effects of glyburide on the regulation of peripheral blood flow in normal humans,https://doi.org/10.1016/0014-2999(94)00732-m,7768272
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and investigates the effect of insulin treatment on serum lipoprotein(a) levels.",effect of insulin treatment on serum lipoprotein(a) in non‐insulin‐dependent diabetes,https://doi.org/10.1111/j.1365-2362.1995.tb01548.x,7781667
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of short-term blood glucose normalization on visual evoked potential latencies, which is a clinically relevant outcome.",improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control,https://doi.org/10.2337/diacare.17.10.1141,7821133
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glyburide as the intervention, and reports clinically relevant outcomes.",comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in niddm,https://doi.org/10.2337/diacare.17.11.1300,7821171
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses sulfonylureas as the intervention, and reports clinically relevant outcomes.",control of diabetes during rehabilitation for diabetic stroke.,https://doi.org/10.1620/tjem.173.399,7825173
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a multicentre, randomised, controlled trial, it includes adults with type 2 diabetes, and it assesses clinically relevant outcomes.","united kingdom prospective diabetes study (ukpds) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years",https://doi.org/10.1136/bmj.310.6972.83,7833731
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glipizide as the intervention, is a double-blind, randomized controlled trial in an outpatient setting, and reports clinically relevant outcomes.",lack of interaction between glipizide and co-trimoxazole,https://doi.org/10.1002/j.1552-4604.1994.tb01972.x,7836551
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not involve an intervention by sulfonylureas or short-acting secretagogues.","ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white americans",https://doi.org/10.1111/j.1464-5491.1994.tb00349.x,7851069
False," The article is a review of metformin's mechanism of action and tolerability, not a study of its effects in comparison to other oral hypoglycemic drugs.","re-evaluation of a biguanide, metformin: mechanism of action and tolerability",https://doi.org/10.1016/1043-6618(94)80104-5,7862618
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glyburide) as the intervention, and reports clinically relevant outcomes.",low-dose oral glyburide reduces fasting blood glucose by decreasing hepatic glucose production in healthy volunteers without increasing carbohydrate oxidation,https://doi.org/10.1097/00000441-199503000-00003,7879817
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes adults with type 2 diabetes, and reports on clinically relevant outcomes.","antihyperglycaemic efficacy, response prediction and dose—response relations of treatment with metformin and sulphonylurea, alone and in primary combination",https://doi.org/10.1111/j.1464-5491.1994.tb00253.x,7895460
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing two sulphonylureas (glibenclamide and gliclazide) in elderly patients with type 2 diabetes, and it reports clinically relevant outcomes such as hypoglycaemic reactions and glycaemic control.",glibenclamide vs gliclazide in type 2 diabetes of the elderly,https://doi.org/10.1111/j.1464-5491.1994.tb00256.x,7895463
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, examining the effect of glyburide dosing on glycemic control in adults with type 2 diabetes.",bedtime dosing of glyburide and the treatment of type ii diabetes mellitus,https://doi.org/10.1097/00000441-199430840-00004,7942982
False," The study does not meet the inclusion criteria as it involves healthy subjects, not adults with type 2 diabetes.","comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, ag-ee 623 zw, during euglycaemic clamp in healthy subjects",https://doi.org/10.1007/bf00417695,7958542
True," The study meets all inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effect of a sulfonylurea (glyburide) in adults with a clinically relevant outcome (hypoglycemic effect).",hypoglycemic activity of glyburide (glibenclamide) metabolites in humans,https://doi.org/10.2337/diacare.17.9.1026,7988301
True," The study meets all the inclusion criteria as it is a good quality study examining the effect of glipizide treatment on postprandial lipaemia in patients with non-insulin-dependent diabetes, and it reports original data.",effect of glipizide treatment on postprandial lipaemia in patients with niddm,https://doi.org/10.1007/bf00404335,7988780
False, The study does not meet the inclusion criteria as it is an in vitro study and does not involve adults with type 2 diabetes in an outpatient setting.,sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages,https://doi.org/10.1016/0021-9150(94)90045-0,8003091
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes adults with type 2 diabetes, and examines the effects of a sulfonylurea (glibenclamide) in combination with felodipine.",short‐term effects of felodipine in hypertensive type ii diabetic males on sulfonylurea treatment,https://doi.org/10.1111/j.1365-2796.1994.tb01119.x,8021573
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a randomized controlled trial, it involves adults with type 1 diabetes, and it examines the effect of glipizide in combination with intensive insulin treatment.",the use of glipizide combined with intensive insulin treatment for the induction of remissions in new onset adult type i diabetes,https://doi.org/10.3109/08916939309014647,8025207
True," The study meets all the inclusion criteria as it is a fair quality study on adults with type 2 diabetes, uses sulphonylurea therapy, and reports clinically relevant outcomes.","effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus",https://doi.org/10.1111/j.1464-5491.1994.tb00274.x,8033529
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glipizide as a sulfonylurea intervention, and reports clinically relevant outcomes.",effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (glut 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients,https://doi.org/10.1007/bf00580757,8043894
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting, and it includes clinically relevant outcomes such as progression or occurrence of microvascular disease and quality of life.","a long‐term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes",https://doi.org/10.1111/j.1365-2796.1994.tb00801.x,8077888
True," The study meets all the inclusion criteria as it is a fair quality study involving adults with type 2 diabetes, uses a relevant intervention (α-glucosidase inhibitor), and reports clinically relevant outcomes.",effect of an α-glucosidase inhibitor on intestinal fermentation and faecal lipids in diabetic patients,https://doi.org/10.1177/030006059302100504,8112483
False," The study does not meet the inclusion criteria as it is not a systematic review or a double-blind, randomized controlled trial, but rather a single study.",continuous versus intermittent sulphonylurea therapy in non-insulin-dependent diabetes mellitus,https://doi.org/10.2165/00002018-199309040-00002,8260118
True," The study meets all the inclusion criteria as it is a systematic review of studies on the prevention of complications in non-insulin-dependent diabetes mellitus, includes adults with type 2 diabetes of different races, ages, and gender, and focuses on clinically relevant outcomes.",prevention of complications in non-insulin-dependent diabetes mellitus (niddm),https://doi.org/10.2165/00003495-199550020-00006,8521759
True," The study meets all the inclusion criteria, including being a systematic review or double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",metabolic benefits deriving from chronic vitamin c supplementation in aged non-insulin dependent diabetics.,https://doi.org/10.1080/07315724.1995.10718526,8568117
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of sulfonylurea on the response of glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion.",response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus,https://doi.org/10.1007/bf00838486,8590785
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses relevant interventions, and is conducted in an outpatient setting, with clinically relevant outcomes.","clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control",https://doi.org/10.1016/s0140-6736(96)90672-8,8684103
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (gliclazide) as the intervention, and reports clinically relevant outcomes.",unchanged gene expression of glycogen synthase in muscle from patients with niddm following sulphonylurea-induced improvement of glycaemic control,https://doi.org/10.1007/bf00422374,8690177
True," The study meets all the inclusion criteria, including being a fair quality study, focusing on adults with type 2 diabetes, and examining the efficacy of combination therapy with insulin and oral hypoglycemic agents in an outpatient setting.",efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type ii diabetes during a 1-year period,https://doi.org/10.7556/jaoa.1996.96.6.346,8690621
True," The study meets all the inclusion criteria, including being a systematic review is not required, but the study is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, and it investigates clinically relevant outcomes related to type 2 diabetes.",does a high-carbohydrate diet have different effects in niddm patients treated with diet alone or hypoglycemic drugs?,https://doi.org/10.2337/diacare.19.5.498,8732716
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",daytime glibenclamide and bedtime nph insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up,https://doi.org/10.1002/(sici)1096-9136(199605)13:5<471::aid-dia103>3.0.co;2-t,8737030
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in adults with type 2 diabetes (NIDDM patients) evaluating the effects of captopril on circulating catecholamine levels and insulin sensitivity.",circulating catecholamines and metabolic effects of captopril in niddm patients,https://doi.org/10.2337/diacare.19.3.226,8742566
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting, and it includes clinically relevant outcomes such as quality of life and progression of microvascular disease.",a comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated niddm patients,https://doi.org/10.2337/diacare.19.3.252,8742572
True," The study meets all inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glipizide) as the intervention, and reports clinically relevant outcomes.",a novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin,https://doi.org/10.1007/bf00576262,8750768
False, The study does not meet the inclusion criteria as it is focused on healthy subjects rather than adults with type 2 diabetes.,effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects,https://doi.org/10.1177/106002809603000103,8773160
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",a dose-response study of glimepiride in patients with niddm who have previously received sulfonylurea agents,https://doi.org/10.2337/diacare.19.8.849,8842603
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of a sulfonylurea (glipizide) in adults with type 2 diabetes, and it reports original data.",the effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in niddm,https://doi.org/10.2337/diacare.19.8.883,8842609
False," The study is about type 1 diabetes mellitus, not type 2 diabetes mellitus, which is the focus of the inclusion criteria.",more uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity,https://doi.org/10.1111/j.1464-5491.1995.tb00390.x,8846678
True," The study meets all the inclusion criteria as it is a fair quality study involving adults with type 2 diabetes, using tolbutamide as a sulfonylurea, and reporting clinically relevant outcomes.",the effect of a very low dose of tolbutamide combined with an α-glucosidase inhibitor in non-insulin-dependent diabetes mellitus,https://doi.org/10.1177/030006059602400505,8895047
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it includes clinically relevant outcomes.",metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas,https://doi.org/10.2337/diacare.19.11.1185,8908377
True," The study is a systematic review is not mentioned, but it is a double-blind, randomized controlled trial in an outpatient setting, and it includes clinically relevant outcomes such as progression or occurrence of microvascular disease and quality of life.","glimepiride, a new once-daily sulfonylurea: a double-blind placebo-controlled study of niddm patients",https://doi.org/10.2337/diacare.19.11.1194,8908379
True," The study meets all inclusion criteria, including being a systematic review of good quality studies on adults with type 2 diabetes, and the abstract provides clinically relevant outcomes.",acarbose: its role in the treatment of diabetes mellitus,https://doi.org/10.1177/106002809603001110,8913408
True," The study meets all the inclusion criteria as it discusses new treatments for type 2 diabetes, includes adults of different races, ages, and genders, and focuses on specific types of interventions (sulfonylureas and short-acting secretagogues) in a systematic manner.",new treatments for patients with type 2 diabetes mellitus,https://doi.org/10.1136/pgmj.72.853.657,8944206
True," The study meets all the inclusion criteria as it is a prospective study evaluating the effects of sulfonylureas on patients with type 2 diabetes, and it includes clinically relevant outcomes such as progression of microvascular disease and all-cause mortality.",the uk prospective diabetes study,https://doi.org/10.3109/07853899608999105,8949976
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glimepiride as the intervention, and reports clinically relevant outcomes.",pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment,https://doi.org/10.1007/s001250050624,8960852
True," The study meets all the inclusion criteria as it is a good quality, double-blind, randomized controlled trial of insulin versus a sulfonylurea (glibenclamide) in adults with type 2 diabetes, and reports clinically relevant outcomes.","niddm: a rapid progressive disease results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment",https://doi.org/10.1007/s001250050626,8960854
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigates the effect of a sulfonylurea (glyburide) in adults with type 2 diabetes, and reports clinically relevant outcomes.","eprosartan, an angiotensin ii receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type ii diabetes mellitus",https://doi.org/10.1002/j.1552-4604.1997.tb04774.x,9055142
False," The study does not meet the inclusion criteria as it does not involve adults with type 2 diabetes, but rather healthy male volunteers.",a study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide,https://doi.org/10.2165/00003088-199700321-00005,9068933
True," The study meets all inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and focuses on the effects of short-acting secretagogues.",novel mody3 mutations in the hepatocyte nuclear factor-1α gene: evidence for a hyperexcitability of pancreatic β-cells to intravenous secretagogues in a glucose-tolerant carrier of a p447l mutation,https://doi.org/10.2337/diab.46.4.726,9075819
True," The study meets all inclusion criteria as it is a systematic review of metformin hydrochloride, includes adults with type 2 diabetes, and discusses clinically relevant outcomes.",metformin hydrochloride: an antihyperglycemic agent,https://doi.org/10.1093/ajhp/54.8.893,9114921
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the efficacy and safety of a sulfonylurea (glibenclamide) with an alpha-glucosidase inhibitor (miglitol) in patients with type 2 diabetes.",the efficacy and safety of miglitol therapy compared with glibenclamide in patients with niddm inadequately controlled by diet alone,https://doi.org/10.2337/diacare.20.5.687,9135927
True," The study meets all the inclusion criteria as it is a double-blind, randomized crossover study of adults with NIDDM comparing the effects of two oral hypoglycemic drugs, glibenclamide and metformin, on ambulatory blood pressure and cardiovascular reactivity.",comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in niddm,https://doi.org/10.2337/diacare.20.5.692,9135928
False," The abstract does not contain original data, as it is a review of existing treatments for type 2 diabetes in the elderly.",oral antihyperglycaemics,https://doi.org/10.2165/00002512-199710050-00001,9143853
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigates the effect of a sulfonylurea (troglitazone) in combination with another oral hypoglycemic agent, and reports clinically relevant outcomes.",effect of combination therapy of troglitazone and sulphonylureas in patients with type 2 diabetes who were poorly controlled by sulphonylurea therapy alone,https://doi.org/10.1002/(sici)1096-9136(199604)13:4<365::aid-dia19>3.0.co;2-m,9162613
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glipizide as the intervention, and reports clinically relevant outcomes.",glipizide-gits does not increase the hypoglycemic effect of mild exercise during fasting in niddm,https://doi.org/10.2337/diacare.20.6.992,9167112
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glimepiride) as the intervention, and is a double-blind, randomized controlled trial in an outpatient setting.",short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus,https://doi.org/10.1177/106002809703100601,9184703
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glyburide as the intervention, and reports clinically relevant outcomes.",pharmacokinetics of oral glyburide in subjects with non-insulin-dependent diabetes mellitus and renal failure,https://doi.org/10.1016/s0272-6386(97)90465-0,9186077
False," The study does not meet the inclusion criteria for intervention as it involves insulin treatment, not sulfonylureas or short-acting secretagogues.",effect of insulin treatment on circulating islet amyloid polypeptide in patients with niddm,https://doi.org/10.1002/(sici)1096-9136(199706)14:6<472::aid-dia388>3.0.co;2-q,9212313
True," The study meets all the inclusion criteria, including being a good quality study, focusing on adults with type 2 diabetes, and examining the effect of a sulfonylurea (tolbutamide) on mortality rates.","glucose tolerance and mortality, including a substudy of tolbutamide treatment",https://doi.org/10.1007/s001250050734,9222648
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effect of a specific oral hypoglycemic drug (troglitazone) on adults with impaired glucose tolerance.",treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.,https://doi.org/10.1172/jci119562,9239399
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, and examines the effect of a sulfonylurea (glibenclamide) on leptin concentrations.","glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with niddm",https://doi.org/10.2337/diacare.20.9.1430,9283792
False, The article is a review paper and does not contain original data.,pathophysiology of type 2 diabetes and modes of action of therapeutic interventions,https://doi.org/10.1001/archinte.1997.00440370028004,9290539
True," The study meets all the inclusion criteria as it is a double-blind, cross-over study in healthy male subjects investigating the pharmacokinetics of glibenclamide with and without voglibose, and it is written in English.",concomitant administration of the ?-glucosidase inhibitor voglibose (ao-128) does not alter the pharmacokinetics of glibenclamide,https://doi.org/10.1007/s002280050354,9403288
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes, uses a relevant intervention (lithium), and reports clinically relevant outcomes.",assisting effects of lithium on hypoglycemic treatment in patients with diabetes,https://doi.org/10.1007/bf02783316,9404682
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of a specific oral hypoglycemic drug (picotamide) on clinically relevant outcomes in adults with type 2 diabetes.",long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.,https://doi.org/10.2337/diabetes.47.3.423,9519749
False," The abstract does not contain original data, as it appears to be a discussion of existing studies rather than presenting new research findings.",is there a concentration-effect relationship for sulphonylureas?,https://doi.org/10.2165/00003088-199834030-00001,9533980
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it reports clinically relevant outcomes.",the effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes,https://doi.org/10.2337/diacare.21.1.2,9538962
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",ukpds 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes,https://doi.org/10.2337/diacare.21.1.87,9538975
True," The study meets all the inclusion criteria as it is a systematic study of the effects of exercise and glibenclamide in patients with type 2 diabetes, conducted in an outpatient setting, and reports original data.",the blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus,https://doi.org/10.1002/(sici)1096-9136(199803)15:3<194::aid-dia546>3.0.co;2-2,9545119
False," The study does not focus on adults with type 2 diabetes, but rather on the impact of smoking cessation on all-cause mortality.",modeling all-cause mortality: projections of the impact of smoking cessation based on the nhefs. nhanes i epidemiologic follow-up study.,https://doi.org/10.2105/ajph.88.4.630,9551006
True," The study meets all the inclusion criteria as it is a good quality study of adults with type 2 diabetes, involves an intervention with a specific type of medication (tolbutamide, metformin), and reports clinically relevant outcomes.",beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the belfast diet study,https://doi.org/10.1002/(sici)1096-9136(199804)15:4<290::aid-dia570>3.0.co;2-m,9585393
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting, and it includes clinically relevant outcomes such as quality of life and all-cause mortality.",beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone,https://doi.org/10.2337/diacare.21.7.1052,9653594
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes original data on the efficacy of acarbose in patients with type 2 diabetes inadequately controlled on conventional oral agents.",acarbose in niddm patients with poor control on conventional oral agents: a 24-week placebo-controlled study,https://doi.org/10.2337/diacare.21.7.1154,9653611
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of a specific sulfonylurea (gliclazide) in a double-blind, randomized controlled trial.",accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a peg 400 suspension of gliclazide,https://doi.org/10.1016/s0168-3659(97)00167-3,9685916
True," The study meets all inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and reports clinically relevant outcomes.",isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the rancho bernardo study,https://doi.org/10.2337/diacare.21.8.1236,9702426
True," This study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of glimepiride in adults with type 2 diabetes, and it reports clinically relevant outcomes such as glycemic control and quality of life.","a placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful",https://doi.org/10.1002/j.1552-4604.1998.tb04471.x,9702849
True," The study meets all inclusion criteria as it is a systematic review is not mentioned but the study is a double-blind, randomized controlled trial, it includes adults with type 2 diabetes, and it assesses clinically relevant outcomes such as glycemic control and quality of life.",troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes,https://doi.org/10.2337/diacare.21.9.1462,9727892
True," The study meets all inclusion criteria as it is a review of the pharmacokinetic properties and effects of metformin, includes adults with type 2 diabetes, and focuses on clinically relevant outcomes.",metformin: an old drug for the treatment of diabetes but a new drug for the protection of the endothelium,https://doi.org/10.1159/000381643,9732337
True," The study meets all inclusion criteria as it is a systematic review of repaglinide, a short-acting secretagogue, in adults with type 2 diabetes, and it reports on clinically relevant outcomes.",repaglinide,https://doi.org/10.2165/00002512-199813020-00008,9739505
False, The study does not meet the inclusion criteria as it is a review paper and does not contain original data.,dietary advanced glycation end products and their potential role in cardiometabolic disease in children,https://doi.org/10.1159/000444053,9742976
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it reports original data on the efficacy and safety of repaglinide in the treatment of type 2 diabetes.",a randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.,https://doi.org/10.2337/diacare.21.11.1897,9802740
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, uses sulfonylureas as an intervention, and reports clinically relevant outcomes.",influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.,https://doi.org/10.2337/diacare.21.11.1925,9802745
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes treated with sulfonylureas or short-acting secretagogues, and it reports clinically relevant outcomes.","high-fat versus high-carbohydrate enteral formulae: effect on blood glucose, c-peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea",https://doi.org/10.1016/s0899-9007(98)00124-5,9834926
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 1 diabetes (IDDM), and examines the impact of previous episodes of hypoglycemic coma on cognitive brain function.",previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in iddm patients on intensive insulin treatment.,https://doi.org/10.2337/diabetes.47.12.1909,9836523
True," The study meets all the inclusion criteria as it is a systematic investigation of the impact of nocturnal hypoglycemia on cognitive dysfunction in type 1 diabetes, conducted in adults with type 1 diabetes, and reports original data.",impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.,https://doi.org/10.2337/diabetes.47.12.1920,9836525
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, involves the use of sulfonylureas (glyburide) and other oral hypoglycemic agents, and reports clinically relevant outcomes.",drug-induced hypoglycemic coma in 102 diabetic patients,https://doi.org/10.1001/archinte.159.3.281,9989540
